Researchers develop tool to more easily detect esophageal cancer cells

July 6, 2018 by Lekan Oguntoyinbo, University of Texas at Arlington
Dr. Zui Pan. Credit: University of Texas at Arlington

Researchers at the University of Texas at Arlington's College of Nursing and Health Innovation have developed a new nanoparticle-based platform for simultaneous imaging and treatment of esophageal cancer.

Together with colleagues from The Ohio State University, researchers manufactured polypeptide , which have near infrared fluorescence for better tissue imaging. They also modified the nanoparticles with tumor targeting properties and then loaded the nanoparticles with a chemotherapy drug.

"This is precision medicine," said Zui Pan, an associate professor of nursing and one of the corresponding authors of a paper on this nanoparticle, which is scheduled to be published in the journal Nature Communications this month. "It is harder to detect the tumor. One common detection method is the use of an endoscopic probe, which shines a white light through your throat. But the problem is the tumor is embedded in the normal tissue and difficult to see. This will help detect the tumor and guide the surgeon to the area that is lit up and surgically remove it, or consider alternative therapies."

Esophageal , the sixth leading cause of cancer death worldwide, is responsible for nearly 16,000 deaths in the United States each year, according to the American Cancer Society. It has few symptoms and is often diagnosed at a later stage. The five-year survival rate is less than 20 percent.

Pan, a leading esophageal cancer researcher, heads a lab that is largely devoted to the study and treatment of the disease. Other collaborators on this study include Mingjun Zhang, a professor in the Department of Biomedical Engineering at The Ohio State University, and his postdoctoral fellow Zhen Fan; Yan Chang, a post-doctoral fellow in Pan's lab and Chaochu Chi, a graduate student who is also in Pan's lab.

The researchers began developing this nanoparticle in 2015, Pan said. She added that in addition to making it easier to see the tumor, the nanoparticle has the ability to carry the chemotherapy drug to the site.

The nanoparticle is injected into the body, travels through the blood stream and accumulates in the tumor area because of its targeting properties, Pan said.

Pan said that in the past there have been some concerns about attempting to use nanoparticles detecting cancer cells because of the potential to introduce unanticipated side effects. It is important to note that this nanoparticle is both biocompatible and biodegradable.

"This is a significant milestone in cancer research, particularly esophageal cancer research," said Anne Bavier, dean of the College of Nursing and Health Innovation. "It is potentially transformative and further builds on the college and the university's efforts to advance health and the human condition."

This is Pan's second breakthrough in esophageal cancer research in the last 12 months. Last fall, she published a study in the FASEB Journal that showed that zinc can inhibit the growth of esophageal cancer cells.

"The long term goal of my research is to help prevent this and to find better, safer and more targeted treatments for esophageal cancer," Pan said. "This is a big step toward that goal."

Explore further: Study says zinc can halt the growth of cancer cells

More information: Zhen Fan et al. Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy, Nature Communications (2018). DOI: 10.1038/s41467-018-04763-y

Related Stories

Study says zinc can halt the growth of cancer cells

September 28, 2017
Zinc supplements can significantly inhibit the proliferation of esophageal cancer cells, according to a new study co-authored by a University of Texas at Arlington researcher.

For patients with esophageal cancer, status of lymph nodes after preoperative therapy determines survival

May 2, 2018
According to a new study, the status of lymph nodes rather than the status of the primary tumor following preoperative neoadjuvant chemotherapy or chemoradiation therapy is the most important factor that determines whether ...

Treatment improved overall survival in elderly patients with early-stage esophageal cancer

April 27, 2017
Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.

Drinking hot tea associated with five-fold increased risk for esophageal cancer for some

February 6, 2018
Consuming hot tea at high temperatures is associated with an increased risk for esophageal cancer in those who also drink alcohol and smoke cigarettes. The findings, based on long-term follow-up in more than 450,000 participants, ...

Fluorescent nanomedicine can guide tumor removal, kill remaining cancer cells

December 21, 2017
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.

Nanoparticles target and kill cancer stem cells that drive tumor growth

June 10, 2015
Many cancer patients survive treatment only to have a recurrence within a few years. Recurrences and tumor spreading are likely due to cancer stem cells that can be tough to kill with conventional cancer drugs. But now researchers ...

Recommended for you

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

Method identified to reduce risk of brain damage in leukemia survivors

September 25, 2018
Children with acute lymphoblastic leukemia (ALL) are at an extremely high risk of sepsis compared to the general population. In the first-published study of its kind, St. Jude Children's Research Hospital scientists have ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.